Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

282 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Phosphatidylserine Synthase PTDSS1 Shapes the Tumor Lipidome to Maintain Tumor-Promoting Inflammation.
Sekar D, Dillmann C, Sirait-Fischer E, Fink AF, Zivkovic A, Baum N, Strack E, Klatt S, Zukunft S, Wallner S, Descot A, Olesch C, da Silva P, von Knethen A, Schmid T, Grösch S, Savai R, Ferreirós N, Fleming I, Ghosh S, Rothlin CV, Stark H, Medyouf H, Brüne B, Weigert A. Sekar D, et al. Among authors: baum n. Cancer Res. 2022 Apr 15;82(8):1617-1632. doi: 10.1158/0008-5472.CAN-20-3870. Cancer Res. 2022. PMID: 35425959
Nanobody-based CD38-specific heavy chain antibodies induce killing of multiple myeloma and other hematological malignancies.
Schriewer L, Schütze K, Petry K, Hambach J, Fumey W, Koenigsdorf J, Baum N, Menzel S, Rissiek B, Riecken K, Fehse B, Röckendorf JL, Schmid J, Albrecht B, Pinnschmidt H, Ayuk F, Kröger N, Binder M, Schuch G, Hansen T, Haag F, Adam G, Koch-Nolte F, Bannas P. Schriewer L, et al. Among authors: baum n. Theranostics. 2020 Feb 3;10(6):2645-2658. doi: 10.7150/thno.38533. eCollection 2020. Theranostics. 2020. PMID: 32194826 Free PMC article.
Nanobody Targeting of Epidermal Growth Factor Receptor (EGFR) Ectodomain Variants Overcomes Resistance to Therapeutic EGFR Antibodies.
Tintelnot J, Baum N, Schultheiß C, Braig F, Trentmann M, Finter J, Fumey W, Bannas P, Fehse B, Riecken K, Schuetze K, Bokemeyer C, Rösner T, Valerius T, Peipp M, Koch-Nolte F, Binder M. Tintelnot J, et al. Among authors: baum n. Mol Cancer Ther. 2019 Apr;18(4):823-833. doi: 10.1158/1535-7163.MCT-18-0849. Epub 2019 Mar 1. Mol Cancer Ther. 2019. PMID: 30824613
Nanobody-Enhanced Targeting of AAV Gene Therapy Vectors.
Eichhoff AM, Börner K, Albrecht B, Schäfer W, Baum N, Haag F, Körbelin J, Trepel M, Braren I, Grimm D, Adriouch S, Koch-Nolte F. Eichhoff AM, et al. Among authors: baum n. Mol Ther Methods Clin Dev. 2019 Sep 16;15:211-220. doi: 10.1016/j.omtm.2019.09.003. eCollection 2019 Dec 13. Mol Ther Methods Clin Dev. 2019. PMID: 31687421 Free PMC article.
Editorial Commentary.
Baum N. Baum N. Urol Pract. 2024 May;11(3):506. doi: 10.1097/UPJ.0000000000000527. Epub 2024 Feb 21. Urol Pract. 2024. PMID: 38447226 No abstract available.
"I couldn't see my friends; the internet was bad, and I hardly went out" - insights into children's and adolescents' experiences of COVID-19 in Germany.
Berner-Rodoreda A, Baum N, Zangerl K, Wachinger J, Hoegl H, Li LY, Bärnighausen T. Berner-Rodoreda A, et al. Among authors: baum n. Int J Qual Stud Health Well-being. 2023 Dec;18(1):2271271. doi: 10.1080/17482631.2023.2271271. Epub 2023 Nov 6. Int J Qual Stud Health Well-being. 2023. PMID: 37930944 Free PMC article.
282 results